Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
申请人:Ligand Pharmaceuticals Incorporated
公开号:US20020183314A1
公开(公告)日:2002-12-05
Novel non-steroidal tricyclic quinolinone and tricyclic quinoline compounds and compositions that are agonists, partial agonists and/or antagonists for androgen receptors (AR), their preparation and their uses are described.
描述了一种新型的非甾体三环喹诺酮和三环喹啉化合物以及对雄激素受体(AR)具有激动剂、部分激动剂和/或拮抗剂作用的组合物,以及它们的制备和用途。